Visudyne (verteporfin) - Novartis
Byooviz (ranibizumab-nuna) - Samsung, AffaMed Therap, Biogen
Zirabev (bevacizumab-bvzr) - Pfizer
Susvimo (ranibizumab port delivery system) - Roche
Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva
Eylea (aflibercept intravitreal) - Regeneron
Vabysmo (faricimab-svoa) - Roche
Beovu (brolucizumab-dbll) - Novartis
Izervay (avacincaptad pegol) - Astellas
Syfovre (pegcetacoplan intravitreal) - Apellis
Pavblu (aflibercept-ayyh) - Amgen
Lucentis (ranibizumab) - Roche, Novartis
Mvasi (bevacizumab-awwb) - Daiichi Sankyo, Amgen, AbbVie
http://www.ncbi.nlm.nih.gov/pubmed/39787576
 
Jan 12, 2025
 
Prev Next